Trade Mark Journal No.2026/041 9 October 2026
WO0000001938923 (1,5,9,42)
Office of origin: European Union Intellectual Property Office (EUIPO)
Date of International Registration:5 August 2026
Date of designation in the UK:
5 August 2026

International priority date claimed: 9 February 2026
(European Union Intellectual Property Office (EUIPO))
(019314742)
- Class 1
- Chemical reagents for the stimulation and/or expansion of cells, in particular of cells of the immune system of mammals including human cells; chemical reagents for the stimulation and/or expansion of T-cells, B-cells or natural killer cells; kits containing chemical reagents for the stimulation and/or expansion of cells, in particular of cells of the immune system of mammals including human cells; kits containing chemical reagents for the stimulation and/or expansion of T-cells, B-cells or natural killer cells.
- Class 5
- Pharmaceutical and veterinary preparations, in particular cells, in particular body cells and cells of the immune system of mammals including human cells; stimulated and/or expanded T-cells, B-cells or natural killer cells.
- Class 9
- Scientific apparatus for the stimulation and/or expansion of cells, in particular of cells of the immune system of mammals including human cells; scientific apparatus for the stimulation and/or expansion of T-cells, B-cells or natural killer cells.
- Class 42
- Scientific and industrial research in the field of biochemistry, diagnostics or pharmaceuticals; services of a biochemical or pharmaceutical laboratory, in particular stimulation and/or expansion of cells, in particular of cells of the immune system of mammals including human cells; stimulation and/or expansion of T-cells, B-cells or natural killer cells (science/research).
TQ Therapeutics GmbH
Representative: SCHIWECK WEINZIERL KOCH PATENTANWÄLTE PARTNERSCHAFT MBB, Ganghoferstrasse 68b, 80339 München, GERMANY